{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:59:57Z","timestamp":1792511997451,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770689"],"award-info":[{"award-number":["81770689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.biopha.2018.07.070","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T22:41:27Z","timestamp":1532040087000},"page":"1182-1187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Effect of dual mTOR inhibitor on TGF\u03b21-induced fibrosis in primary human urethral scar fibroblasts"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7374-775X","authenticated-orcid":false,"given":"Shanlong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuance","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2018.07.070_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrurol.2013.275","article-title":"Male urethral strictures and their management","volume":"11","author":"Hampson","year":"2014","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.070_bib0010","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.juro.2009.06.027","article-title":"Stricture recurrence after urethroplasty: a systematic review","volume":"182","author":"Meeks","year":"2009","journal-title":"J. Urol."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2018.07.070_bib0015","doi-asserted-by":"crossref","first-page":"E296","DOI":"10.5489\/cuaj.1661","article-title":"Stricture length and etiology as preoperative independent predictors of recurrence after urethroplasty: a multivariate analysis of 604 urethroplasties","volume":"8","author":"Kinnaird","year":"2014","journal-title":"Can. Urol. Assoc. J."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.070_bib0020","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.juro.2007.01.041","article-title":"Male urethral stricture disease","volume":"177","author":"Santucci","year":"2007","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.070_bib0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1464-410X.2007.06904.x","article-title":"A morphometric analysis of bulbar urethral strictures","volume":"100","author":"Cavalcanti","year":"2007","journal-title":"BJU Int."},{"issue":"2 Pt 2","key":"10.1016\/j.biopha.2018.07.070_bib0030","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0022-5347(17)35572-6","article-title":"Biochemical characterization and quantitation of the collagenous components of urethral stricture tissue","volume":"150","author":"Baskin","year":"1993","journal-title":"J. Urol."},{"key":"10.1016\/j.biopha.2018.07.070_bib0035","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.12688\/f1000research.9741.1","article-title":"Advances in urethral stricture management","volume":"5","author":"Gallegos","year":"2016","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.biopha.2018.07.070_bib0040","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","article-title":"Peyronie\u2019s disease is associated with an increase in transforming growth factor-beta protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J. Urol."},{"issue":"19","key":"10.1016\/j.biopha.2018.07.070_bib0045","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2018.07.070_bib0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11010-014-2104-5","article-title":"Crosstalk between TGF-beta1 and CXCR3 signaling during urethral fibrosis","volume":"394","author":"Xie","year":"2014","journal-title":"Mol. Cell Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.070_bib0055","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.juro.2015.02.014","article-title":"Transforming growth factor-beta1 induced urethral fibrosis in a rat model","volume":"194","author":"Sangkum","year":"2015","journal-title":"J. Urol."},{"issue":"23","key":"10.1016\/j.biopha.2018.07.070_bib0060","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.070_bib0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.110.178624","article-title":"Rapamycin inhibits formation of urethral stricture in rabbits","volume":"338","author":"Chong","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.070_bib0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0625.2007.00550.x","article-title":"mTOR as a potential therapeutic target for treatment of keloids and excessive scars","volume":"16","author":"Ong","year":"2007","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2018.07.070_bib0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jdermsci.2014.02.002","article-title":"Effects of the immunosuppressant rapamycin on the expression of human alpha2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts","volume":"74","author":"Tamaki","year":"2014","journal-title":"J. Dermatol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2018.07.070_bib0080","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/1535-7163.MCT-10-1099","article-title":"Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin","volume":"10","author":"Bhagwat","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.biopha.2018.07.070_bib0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrclinonc.2010.21","article-title":"mTOR signaling and drug development in cancer","volume":"7","author":"Dancey","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2018.07.070_bib0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/lrb.2008.1006","article-title":"Efficacy of rapamycin in scleroderma: a case study","volume":"6","author":"Fried","year":"2008","journal-title":"Lymphat. Res. Biol."},{"issue":"7\u20138","key":"10.1016\/j.biopha.2018.07.070_bib0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.drudis.2011.02.008","article-title":"Targeting the mTOR kinase domain: the second generation of mTOR inhibitors","volume":"16","author":"Zhang","year":"2011","journal-title":"Drug. Discov. Today"},{"issue":"5-6","key":"10.1016\/j.biopha.2018.07.070_bib0100","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.5489\/cuaj.3435","article-title":"Effect of adipose tissue-derived stem cell injection in a rat model of urethral fibrosis","volume":"10","author":"Sangkum","year":"2016","journal-title":"Can. Urol. Assoc. J."},{"issue":"6","key":"10.1016\/j.biopha.2018.07.070_bib0105","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.eururo.2016.04.022","article-title":"Adipose-derived stem cells counteract urethral stricture formation in rats","volume":"70","author":"Castiglione","year":"2016","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.070_bib0110","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0022-5347(05)67105-4","article-title":"The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model","volume":"164","author":"Nagler","year":"2000","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.070_bib0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/end.2010.0514","article-title":"Halofuginone-coated urethral catheters prevent periurethral spongiofibrosis in a rat model of urethral injury","volume":"25","author":"Krane","year":"2011","journal-title":"J. Endourol."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.070_bib0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3349\/ymj.2013.54.2.437","article-title":"Rapamycin inhibits transforming growth factor \u03b21-induced fibrogenesis in primary human lung fibroblasts","volume":"54","author":"Gao","year":"2013","journal-title":"Yonsei Med. J."},{"issue":"5 Pt 1","key":"10.1016\/j.biopha.2018.07.070_bib0125","first-page":"L814","article-title":"Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3","volume":"276","author":"Eickelberg","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2018.07.070_bib0130","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/sj.ki.5000161","article-title":"Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis","volume":"69","author":"Wu","year":"2006","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.biopha.2018.07.070_bib0135","doi-asserted-by":"crossref","first-page":"e106155","DOI":"10.1371\/journal.pone.0106155","article-title":"A critical role for the mTORC2 pathway in lung fibrosis","volume":"9","author":"Chang","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2018.07.070_bib0140","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ceb.2011.09.003","article-title":"mTOR signaling in disease","volume":"23","author":"Dazert","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.070_bib0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.070_bib0150","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2018.07.070_bib0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.2008.18.9514","article-title":"Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer","volume":"27","author":"Wolpin","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.07.070_bib0160","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/1471-2407-10-368","article-title":"Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies","volume":"10","author":"Javle","year":"2010","journal-title":"BMC Cancer"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218322704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218322704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T15:31:49Z","timestamp":1750865509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218322704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":32,"alternative-id":["S0753332218322704"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.070","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of dual mTOR inhibitor on TGF\u03b21-induced fibrosis in primary human urethral scar fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}